Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Engineering FlowGERO-Chips: Complex flow-enabled long-term multicellular blood vessel-chips for enabling geroscience

Award Number: R21AG102466
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Engineering FlowGERO-Chips: Complex flow-enabled long-term multicellular blood vessel-chips for enabling geroscience - Engineering FlowGERO-Chips: Flow reversal-enabled long-term vessel-chips for modeling geroscience Age is a major risk factor for cardiovascular disease (CVD) where a significant contributor to vascular dysfunction is the age-associated impairment of arterial hemodynamics, specifically adverse retrograde or oscillatory blood flow, known as flow reversal. Current preclinical in vitro models, such as microphysiological systems incorporating cells from Hutchinson-Gilford Progeria Syndrome (HGPS) patients, have some limitations because they represent a pathological state from the initial time, often cannot form a fully confluent lumen, and typically remain stable for only a few days, thus failing to capture the progressive dynamics of aging. To overcome these limitations, we propose the development of FlowGERO-Chips, a New Approach Method (NAM) designed to replicate human aged arteriolar blood vessels and assess treatments relevant to geroscience. The FlowGERO- Chip is innovative in three key ways: it utilizes normal induced pluripotent stem cell (iPSC)-derived endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in a multicellular architecture; it is stable and supports long-term (up to 90-day) culture; and it enables the time-dependent assessment of EC-VSMC crosstalk under clinically-relevant flow reversal conditions. For Aim 1, we will engineer the FlowGERO-Chip with a cylindrical lumen of iPSC-ECs surrounded by extracellular matrix-embedded iPSC-VSMCs, mimicking in vivo vessel structure. Using the custom-engineered Hemadyne perfusion system, which can accurately reproduce pathological flow reversal waveforms, we will expose the chips to normal versus reversed arterial periodic flow for up to 90 days. We anticipate that flow reversal will accelerate a shift towards a senescent phenotype, characterized by increases in senescence associated biomarkers. For Aim 2, we will validate the FlowGERO- Chips by administering a telomerase (hTERT) mRNA therapy, which has been shown to reverse vascular senescence in vivo, either alone or in combination with the senolytic cocktail Dasatinib + Quercetin. We will monitor longitudinal changes in senescence-associated secretory phenotype (SASP) markers, expecting that these interventions will reverse or delay the EC and VSMC senescence induced by reversed/retrograde flow waveforms and extend the viability of the chip. In summary, this platform will provide a robust tool for predictive studies and preclinical drug discovery related to cardiovascular aging.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $420,052 )
2026	2026	TEXAS A&M ENGINEERING EXPERIMENT STATION	3124 TAMU	COLLEGE STATION	TX	77843	BRAZOS	USA	Aging Research	000	1	8/21/2026	NEW	$420,052
														Subtotal = $420,052

Grand Total All Awards = $420,052

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Engineering FlowGERO-Chips: Complex flow-enabled long-term multicellular blood vessel-chips for enabling geroscience

Award Number: R21AG102466

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer